Search

for
Search:

Did you mean Myotonic Dystrophy Type 1?

GlossaryMyotonic Dystrophy Type 1

genetic disorder causing progressive muscle wasting and weakness

Myotonic Dystrophy Type 1 (DM1), also known as Steinert disease, is a genetic disorder characterized by progressive muscle wasting and weakness. It is caused by a mutation in the DMPK gene, leading to an abnormal expansion of DNA repeats that disrupts normal cellular function. Symptoms can include muscle stiffness (myotonia), cataracts, heart conduction defects, and endocrine changes, and the severity can vary widely among individuals.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 81 results

research Cutaneous Features of Myotonic Dystrophy Types 1 and 2: Implications of Premature Aging and Vitamin D Homeostasis

18 citations , November 2016 in “Neuromuscular Disorders”

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

research Myotonic Dystrophy Type 1: Enhancing Patient Management Through Genetic and Multisystem Studies

January 2023

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

research Cellular Senescence and Aging in Myotonic Dystrophy

4 citations , February 2022 in “International Journal of Molecular Sciences”

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

research Myotonic Dystrophy: A Progeroid Disease?

41 citations , July 2018 in “Frontiers in Neurology”

Myotonic dystrophy may be classified as a segmental progeroid disorder.

research A Failure to Relax: Case of Myotonia in a 31-Year-Old Man

October 2007 in “PubMed”

The man had myotonia, which caused delayed hand grip relaxation.

View more "myotonic dystrophy type 2" in research →

Community Join

1 / 1 results

community DHT Isn’t the Only Factor in Hair Loss and That Might Be the Key to a Real Cure

in Research/Science 361 upvotes 1 week ago

Hair loss involves more than just DHT, with genetic factors like TRPS affecting hair follicles. Treatments such as Amplifica's AMP-601 and AMP-303 target stem cells for potential hair growth solutions.